Literature DB >> 16054492

Effect of a CIDR insert and flunixin meglumine, administered at the time of embryo transfer, on pregnancy rate and resynchronization of estrus in beef cattle.

S H Purcell1, W E Beal, K R Gray.   

Abstract

The objectives of this study were to evaluate the effects of flunixin meglumine (FM), an inhibitor of PGF(2alpha) synthesis, and insertion of an intravaginal progesterone-releasing device (CIDR), on pregnancy rates in beef cattle embryo transfer (ET) recipients, and to examine the effect of a CIDR after embryo transfer on the synchrony of the return to estrus in non-pregnant recipients. Cows (n=622) and heifers (n=90) at three locations were assigned randomly to one of four groups in a 2x2 factorial arrangement of treatments with FM administration (500 mg i.m.) 2-12 min prior to ET, and insertion of a CIDR (1.38 g progesterone) immediately following ET as main effects. Fresh or frozen embryos (Stage=4 or 5; Grade=1 or 2) were transferred on Days 6-9 of the estrous cycle and CIDR devices were removed 13 days after ET. Recipients at Location 2 only were observed for signs of return to estrus. Recipients that returned to estrus at Location 2 were either bred by AI or received an embryo 7 days after estrus. Following the initial ET, there was an FMxlocation interaction on pregnancy rate (P<0.01; Location 1, 89% versus 57%; Location 2, 69% versus 64%; Location 3, 64% versus 67% for FM versus no FM, respectively). Pregnancy rates of embryo recipients were not affected by CIDR administration (P>0.05; 65% with CIDR, 70% without CIDR), however, the timing of the return to estrus was more synchronous (P<0.01) for recipients given a CIDR. Pregnancy rate of recipients bred following a return to estrus did not differ between cows receiving or not receiving a CIDR for resynchronization (P>0.13). Effects of FM on pregnancy rate were location dependent and CIDR insertion at ET improved synchrony of the return to estrus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054492     DOI: 10.1016/j.theriogenology.2004.12.015

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  6 in total

1.  Dynamics of Progesterone, TNF- α , and a Metabolite of PGF2 α in Blood Plasma of Beef Cows following Embryo Transfer.

Authors:  M C Mason; J Copeland; E J Cuadra; T H Elsasser; Y Jung; J Larson
Journal:  Vet Med Int       Date:  2014-10-02

Review 2.  The Effect of Stress on Reproduction and Reproductive Technologies in Beef Cattle-A Review.

Authors:  Aitor Fernandez-Novo; Sonia S Pérez-Garnelo; Arantxa Villagrá; Natividad Pérez-Villalobos; Susana Astiz
Journal:  Animals (Basel)       Date:  2020-11-11       Impact factor: 2.752

3.  Effect of xylazine, detomidine, medetomidine and dexmedetomidine during laparoscopic SCNT embryo transfer on pregnancy rate and some physiological variables in goats.

Authors:  Seyed Morteza Aghamiri; Amir Saeed Samimi; Mehdi Hajian; Amir Masoud Samimi; Amin Oroumieh
Journal:  BMC Vet Res       Date:  2022-03-15       Impact factor: 2.741

4.  Effect of post artificial insemination treatment with two different progesterone intravaginal devices on conception and synchronization of the returning estrus in Japanese Black cows.

Authors:  Naoki Yamamoto; Ryo Nishimura; Yosuke Gunji; Makoto Saneshige; Kensuke Kiriki; Mitsugu Hishinuma
Journal:  J Vet Med Sci       Date:  2018-10-18       Impact factor: 1.267

Review 5.  The incompletely fulfilled promise of embryo transfer in cattle-why aren't pregnancy rates greater and what can we do about it?

Authors:  Peter J Hansen
Journal:  J Anim Sci       Date:  2020-11-01       Impact factor: 3.159

Review 6.  A Critical Overview on Prostaglandin Inhibitors and Their Influence on Pregnancy Results after Insemination and Embryo Transfer in Cows.

Authors:  Bartłomiej M Jaśkowski; Adam Opałka; Marek Gehrke; Magdalena Herudzińska; Jarosław Czeladko; Walter Baumgartner; Jędrzej M Jaśkowski
Journal:  Animals (Basel)       Date:  2021-11-24       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.